Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
CheManager, 20 October 2020
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Silicon Republic, October 2, 2020
Pharmaceutical Technology, 2 Junho 2021
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
High Performance, High-Dose Capsule DPI.
Manufacturing Chemist, 3 May 2023